Enveric Biosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $647 |
Gross Profit | -84 | -85 | 562 |
EBITDA | -1,813 | -2,391 | -4,195 |
EBIT | -1,897 | -2,477 | -4,280 |
Net Income | -1,879 | -2,456 | -3,435 |
Net Change In Cash | 0 | 0 | 647 |
Free Cash Flow | -2,889 | -2,598 | -1,751 |
Cash | 3,502 | 6,356 | 2,287 |
Basic Shares | 7,587 | 4,001 | 2,348 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $39,914 |
Gross Profit | -408 | -435 | -681 | -120 |
EBITDA | -17,139 | -19,634 | -63,966 | -6,298 |
EBIT | -17,140 | -20,069 | -64,648 | -6,419 |
Net Income | -17 | -18,471 | -48,976 | -6,386 |
Net Change In Cash | 0 | 0 | 0 | 39,914 |
Free Cash Flow | -14,099 | -17,730 | -12,322 | -3,932 |
Cash | 2,287 | 17,723 | 17,355 | 1,578 |
Basic Shares | 2,159 | 1,446 | 472 | 115 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.25 |
2024-03-31 | -$0.42 |
2023-12-31 | -$1.47 |
2023-09-30 | -$1.30 |
